In mechanism, Yamaguchi et al. suggested that MRGBP promoted cancer cell growth in CRC by interacting with BRD8, and inhibiting BRD8 could improve CRC chemotherapy sensitivity [49]. Here, MRGBP is linked to colorectal carcinoma.